SEARCH RESULTS

26 RESULTS

Eric M. Reiman on Biogen/Eisai Halt Phase 3 Aducanumab Trials

COMMENT This is heartbreaking news for affected persons and their families, our valued research participants, and all stakeholders in the fight against AD. It is also heartbreaking for our Biogen colleagues, who have advanced the development of this drug in an ...

Eric M. Reiman on Liver Tox Ends Janssen BACE Program

COMMENT While last week’s announcement is disappointing, we believe that BACE inhibitors still hold promise in stopping the accumulation of amyloid and preventing the clinical onset of Alzheimer’s disease—particularly in healthy people who are at increased risk ...

Current Filters

  • TYPE: Comment x
  • Commentator: Reiman, Eric M x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE